Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

[1]  P. Reichard,et al.  Mitochondrial DNA Depletion and Thymidine Phosphate Pool Dynamics in a Cellular Model of Mitochondrial Neurogastrointestinal Encephalomyopathy* , 2006, Journal of Biological Chemistry.

[2]  Y. Lai,et al.  Identification of the Mitochondrial Targeting Signal of the Human Equilibrative Nucleoside Transporter 1 (hENT1) , 2006, Journal of Biological Chemistry.

[3]  G. Plazzi,et al.  Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. , 2006, Gastroenterology.

[4]  J. Arenas,et al.  Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIE , 2005, Neuromuscular Disorders.

[5]  A. V. van Kuilenburg,et al.  Late‐onset MNGIE due to partial loss of thymidine phosphorylase activity , 2005, Annals of neurology.

[6]  P. Reichard,et al.  Mitochondrial Deoxyribonucleotides, Pool Sizes, Synthesis, and Regulation* , 2004, Journal of Biological Chemistry.

[7]  Yurong Lai,et al.  Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.

[8]  M. Hirano,et al.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes , 2004, The neurologist.

[9]  M. Hirano,et al.  ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy. , 2003, Human molecular genetics.

[10]  L. Wheeler,et al.  Deoxyribonucleotide Pool Imbalance Stimulates Deletions in HeLa Cell Mitochondrial DNA* , 2003, Journal of Biological Chemistry.

[11]  P. Reichard,et al.  Origins of mitochondrial thymidine triphosphate: Dynamic relations to cytosolic pools , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Muddle,et al.  Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. , 2003, Human molecular genetics.

[13]  M. Hirano,et al.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. , 2003, The Journal of clinical investigation.

[14]  M. Hirano,et al.  Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. , 2003, Biochemical and biophysical research communications.

[15]  J. Duley,et al.  Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE) , 2002, Journal of Inherited Metabolic Disease.

[16]  J. Leffert,et al.  Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update. , 2002, Biochimica et biophysica acta.

[17]  I. Nishino,et al.  Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase* , 2002, The Journal of Biological Chemistry.

[18]  S. Dimauro,et al.  Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations , 2000, Annals of neurology.

[19]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[20]  S. Salani,et al.  Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome , 1998, Neurology.

[21]  R. Bicknell,et al.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. , 1998, The Biochemical journal.

[22]  T. Kato,et al.  Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. , 1996, Biochimica et biophysica acta.

[23]  K. Funa,et al.  Neurons of the peripheral nervous system express thymidine phosphorylase , 1995, Neuroscience Letters.

[24]  A. Harris,et al.  Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study , 1995, The Journal of pathology.

[25]  F. Naguib,et al.  Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. , 1993, Cancer research.

[26]  K. Miyazono,et al.  Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene , 1991, Molecular and cellular biology.

[27]  K. Miyazono,et al.  Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form. , 1990, Cell regulation.

[28]  T. Furukawa,et al.  Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. , 1990, Biochimica et biophysica acta.

[29]  S. Dimauro,et al.  Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase , 1987, Acta Neuropathologica.

[30]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[31]  P. Wiernik,et al.  Pharmacokinetic studies during phase I trials of high-dose thymidine infusions. , 1979, Cancer research.

[32]  M. Friedkin,et al.  The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue. , 1954, The Journal of biological chemistry.

[33]  I. Nishino,et al.  Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. , 2004, Clinical chemistry.

[34]  G. Amidon,et al.  Membrane Transporters as Drug Targets , 2002, Pharmaceutical Biotechnology.

[35]  J. Mackey,et al.  Nucleoside transporters of mammalian cells. , 1999, Pharmaceutical biotechnology.